TRV GP VI, LLC

Position in RAPP — Rapport Therapeutics, Inc.

CIK 1990716 Boston, MA

Position in RAPP

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$40,387,314

+$10,060,483 QoQ

Shares Held

969,218

0.0% QoQ

Ownership

2.02%

of shares outstanding

% of Portfolio

17.39%

of 13F equity value

Holder Rank

#13

of 159 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TRV GP VI, LLC holds $232,275,393 across 4 Biotechnology names. RAPP ranks #3 (17.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SEPN	Septerna, Inc.	4,211,659	$141,048,459
2	SPTX	Seaport Therapeutics, Inc.	2,061,222	$44,769,741
3	RAPP	Rapport Therapeutics, Inc. This page	969,218	$40,387,314
4	TNGX	Tango Therapeutics, Inc.	194,174	$6,069,879

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$40,387,314	969,218	0.0%	Shares	Sole	2026-08-10
2026-03-31	$30,326,831	969,218	0.0%	Shares	Sole	2026-05-07
2025-12-31	$29,406,074	969,218	0.0%	Shares	Sole	2026-02-13
2025-09-30	$28,785,774	969,218	0.0%	Shares	Sole	2025-11-13
2025-06-30	$11,020,008	969,218	0.0%	Shares	Sole	2025-08-08
2025-03-31	$9,721,256	969,218	0.0%	Shares	Sole	2025-05-09
2024-12-31	$17,193,927	969,218	—	Shares	Sole	2025-02-13
No filing history on record for this holder in this stock.